quinazolines has been researched along with indican in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, S; Hirose, Y; Miyazaki, H; Nishijima, F; Niwa, T; Shimizu, H; Zghonda, N; Zrelli, H | 1 |
| Exner, M; Gmeiner, BM; Hermann, M; Jirovetz, L; Kapiotis, S; Laggner, H; Praschberger, M; Wanner, J | 1 |
2 other study(ies) available for quinazolines and indican
| Article | Year |
|---|---|
Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells.
Topics: Acetylcysteine; Angiotensin II; Animals; Arteriosclerosis; Cells, Cultured; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Indican; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Tyrphostins; Up-Regulation | 2012 |
The uremic toxin indoxyl sulfate acts as a pro- or antioxidant on LDL oxidation.
Topics: Amidines; Antioxidants; Atherosclerosis; Copper; Hemin; Humans; Hydrogen Peroxide; Indican; Lipid Peroxidation; Lipid Peroxides; Lipoproteins, LDL; Oxidation-Reduction; Oxidative Stress; Peroxidase; Quinazolines; Renal Insufficiency, Chronic; Uremia | 2014 |